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ARTICLE
Mrp1 is involved in lipid presentation and iNKT cell
activation by Streptococcus pneumoniae
Shilpi Chandra1, James Gray2, William B. Kiosses1, Archana Khurana1, Kaori Hitomi1, Catherine M. Crosby1,
Ashu Chawla3, Zheng Fu 3, Meng Zhao1, Natacha Veerapen4, Stewart K. Richardson5, Steven A. Porcelli6,
Gurdyal Besra 4, Amy R. Howell5, Sonia Sharma2,7, Bjoern Peters8,9 & Mitchell Kronenberg 1,10
Invariant natural killer T cells (iNKT cells) are activated by lipid antigens presented by CD1d,
but the pathway leading to lipid antigen presentation remains incompletely characterized.
Here we show a whole-genome siRNA screen to elucidate the CD1d presentation pathway. A
majority of gene knockdowns that diminish antigen presentation reduced formation of
glycolipid-CD1d complexes on the cell surface, including members of the HOPS and ESCRT
complexes, genes affecting cytoskeletal rearrangement, and ABC family transporters. We
validated the role in vivo for the multidrug resistance protein 1 (Mrp1) in CD1d antigen
presentation. Mrp1 deﬁciency reduces surface clustering of CD1d, which decreased iNKT cell
activation. Infected Mrp1 knockout mice show decreased iNKT cell responses to antigens
from Streptococcus pneumoniae and were associated with increased mortality. Our results
highlight the unique cellular events involved in lipid antigen presentation and show how
modiﬁcation of this pathway can lead to lethal infection.
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C luster of differentiation 1 (CD1) molecules are non-polymorphic major histocompatibility complex (MHC)class I-like proteins. They are found in most vertebrates
and their hydrophobic antigen-binding grooves present lipids
rather than peptide antigens1. In humans there are four CD1
isotypes: CD1A, CD1B, CD1C, and CD1D, but there is only a
single CD1D ortholog in mice2. These proteins are expressed as
heterodimers consisting of CD1 heavy chains noncovalently
paired with β2-microglobulin3. CD1 molecules trafﬁck through
endosomes, and their distribution in early versus late endosomes
differs according to the CD1 isotype4. Overall, their localization
has more in common with MHC class II than MHC class I
intracellular trafﬁcking5.
Invariant natural killer T cells (iNKT cells) recognize antigens
presented by CD1d, and their speciﬁcity for bacterial and self-
glycolipid antigens is highly conserved6. iNKT cells are char-
acterized by the expression of a semi-invariant T cell receptor
(TCR) composed of a conserved α chain and a limited repertoire
of β chains7. These lymphocytes share features with innate
immune cells, and they have been widely studied because
they inﬂuence many types of immune responses in mice and
humans8,9.
While there is much information on the generation and
loading of peptides into MHC class I and class II molecules, lipid
antigen presentation has been examined less extensively. A few
relevant molecules involved in either lipid antigen uptake, car-
bohydrate processing10, CD1d intracellular trafﬁc11, or antigen
loading in lysosomal compartments12–16 have been identiﬁed but
many relevant steps remain unknown. Mouse CD1d is an
excellent prototype for studying CD1-mediated antigen pre-
sentation, not only because it stimulates the well-studied
iNKT cells but also, as the only mouse CD1 isotype, it recircu-
lates through various compartments, including early and late
endosomes and lysosomes. Mouse CD1d ﬁrst appears on the cell
surface by taking a default pathway from the endoplasmic reti-
culum (ER) to the Golgi apparatus and then to the cell surface. It
then is internalized through a process that involves the clathrin-
dependent adaptor protein AP-2, and after multiple rounds of
recycling, goes to late endosomes and lysosomes in a process
mediated by the adaptor AP-3, before ﬁnally returning to the cell
surface17–19. Endosomal trafﬁcking of CD1d is mediated by a
YQDI motif in its short cytoplasmic tail, which allows it to
interact with the adaptor protein complexes. CD1d can be
expressed on the cell surface without this critical motif19,20, but in
that case its presentation of some glycolipids is impaired10.
In order to obtain a more comprehensive understanding of the
pathway leading to lipid antigen presentation by CD1d, we per-
formed a genome-wide small interfering RNA (siRNA) screen in
a mouse macrophage cell line loaded with a glycolipid antigen
that requires lysosomal carbohydrate removal for its presenta-
tion10. In this way, we set out to identify genes related to how
glycolipid antigens are taken up by antigen-presenting cells
(APCs), processed, and loaded into CD1d. Similarly, we wished to
characterize genes important for CD1d trafﬁc and surface
expression. As a result of the screen, here we identify genes
involved in lipid antigen presentation to iNKT cells. These genes
are related to vesicular trafﬁc and fusion, and they affect locali-
zation of CD1d and/or antigen. Here we show that Abcc1, an
ATP transporter, affects CD1d clustering and localization to lipid
membrane rafts and is involved in lipid presentation and the
protective antibacterial response of iNKT cells.
Results
Global screen for lipid antigen presentation. We performed a
genome-wide siRNA screen using a mouse, whole-genome siRNA
library to target a total of 17,660 genes, with a pool of four siRNA
oligonucleotides per target gene. Because of the large number of
cells required, we used transformed APCs and immortalized
iNKT cell (hybridoma) responders. The APCs used were a mouse
Cd1d1 transfectant of the J774 macrophage cell line (J774-CD1d),
which exhibits a high RNAi uptake efﬁciency and target
gene knockdown (Supplementary Fig. 1). The antigen used was
galactose (α1-2) α-galctosyl ceramide (GalGalCer), which
requires internalization to late endosomes or lysosomes, as well as
carbohydrate processing of the disaccharide to a monosaccharide-
glycolipid by α-galactosidase A, in order to be recognized10.
Furthermore, recognition of GalGalCer also requires that CD1d
localize to late endosomes/lysosomes, where antigen loading takes
place10. The use of this antigen therefore allowed us to assess
effects on various processes leading to iNKT cell stimulation,
including antigen uptake, trafﬁc in APCs to lysosomes, carbo-
hydrate processing, CD1d trafﬁcking to lysosomes, antigen
loading, and movement of CD1d-lipid antigen complexes to the
cell surface. After siRNA knockdown, J774-CD1d cells were
exposed to GalGalCer, and the ability of an iNKT cell hybridoma
to produce interleukin (IL)-2 in response to antigenic stimulation
provided a convenient and robust readout for antigen presenta-
tion (Fig. 1a).
In the primary whole-genome screen, by excluding siRNA
knockdowns that signiﬁcantly diminished APC viability, we
identiﬁed 1027 genes in the “down” category (Fig. 1b), corre-
sponding to <30% of the control IL-2 release remaining following
gene depletion (Supplementary Data 1). We focused on those
genes that caused decreased CD1d-mediated antigen presentation
after knockdown and carried out a secondary re-screen of 1027
candidate genes. In general, due to assay variability, the degree of
IL-2 suppression in the secondary screen was lower. By using 50%
knockdown as a cutoff, we thereby validated 424 hits (Supple-
mentary Data 2).
Functional classiﬁcation. To functionally annotate the identiﬁed
genes, we classiﬁed them based on Gene Ontology (GO) analysis,
employing Cytoscape21. Based on this analysis, 70 categories of
cellular processes and structures were identiﬁed as participating
in a positive way in CD1d-mediated antigen presentation (Sup-
plementary Data 3). The processes identiﬁed include 14 GO
classes likely to be directly related to the cell biology of antigen
presentation, such as those including transport, lysosomes,
endosomes, and organelle organization. These categories are lis-
ted in Supplementary Table 1 along with the list of genes in each
category. A total of 207 genes (49%) were identiﬁed in these GO
categories, and prioritized for further study. Classes that are
related less directly to the cell biology of antigen presentation, but
that could have important effects, including transcription, meta-
bolism, and signal transduction, were also identiﬁed.
To reduce false positives, we veriﬁed expression of the hits in
primary macrophages; using a microarray analysis comparing
expression of genes in J774-CD1d cells to peritoneal macrophages
from BALB/c mice, the strain of origin of the J774 cells. The
expression patterns were highly similar and of the candidate
genes identiﬁed, out of 207 genes, 141 were found to be expressed
above the minimum cutoff, as described in Methods, by both cell
types.
To analyze for off-target effects, we performed a deconvolution
screen by testing each of the four single siRNAs from each
oligonucleotide pool. We used the criteria of >50% inhibition of
antigen presentation by at least two of the four siRNAs for
further inclusion. As a result, we identiﬁed 48 genes as having
the most robust inﬂuence (Fig. 2) listed in Supplementary
Data 4, including several previously reported to be important for
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presentation of lipid antigens by CD1d, including B2m, Psap,
encoding the lysosomal protein prosaposin, which is important
for glycosphingolipid (GSL) metabolism, and Vps11, a member of
the homotypic fusion and protein sorting (HOPS) complex
important for tethering vesicles for fusion12,22–26.
To determine the likely protein–protein interactions among the
identiﬁed genes, we used knowledge-based Ingenuity Pathway
Analysis (IPA; Ingenuity Systems). Three functional networks were
identiﬁed containing >5 genes that included 46 out of 48 identiﬁed
genes and their interacting partners. A network involved in protein
and vesicle trafﬁcking encompassed 23 identiﬁed genes (Fig. 3),
including genes in the HOPS and soluble N-ethyl maleimide
sensitive factor attachment protein receptor (SNARE) complexes
involved in vesicle tethering and fusion, as well as other genes such
as Rhob and Snx20, also involved in protein trafﬁcking. The other
networks identiﬁed (Supplementary Fig. 2) include lipid antigen
presentation (12 identiﬁed genes) and cell morphology and
interactions (11 identiﬁed genes). Lipid antigen presentation
includes Cd1d, B2m, and Psap, already known to be involved in
this process and genes involved in lipid metabolism (Abcc1, Cln8,
Gal3st, Glb1, and Psap). The cell morphology and cell–cell signaling
and interaction network includes Dock2, Elmo1, Prad6a, and Was.
A number of the selected genes have been shown to be related
to disease states (using diseases tool—diseases.jensenlab.org) such
as lysosomal storage diseases, including Niemann-Pick (Glb1
and Gal3st), Fabry (Psap), Krabbe disease (Glb1 and Psap),
Hermansky-Pudlak syndrome (Tsg101 and Vps16), some of which
have been associated with deﬁcient iNKT cell differentiation as
well as defective antigen presentation27. Several of the genes
identiﬁed are reported to be involved in infections, autoimmune
and inﬂammatory diseases, or cancer (Supplementary Table 2).
We were not able to identify all the genes previously reported to be
involved in CD1d-mediated antigen presentation, however,
perhaps because the knockdowns were not complete2,11,13,25.
Predominant effects on CD1d-lipid antigen complexes. Redu-
cing the supply of peptide antigens markedly decreases surface
expression of MHC class I proteins28, but we found few genes
that decreased surface expression of CD1d. Of the 48 selected
genes, signiﬁcantly decreased CD1d expression was observed only
in a few cases. These included the gene encoding cytoskeletal
protein Pfn3; Cyp4b1, which is an endoplasmic reticulum protein
and is known to be involved in metabolism and synthesis of
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Fig. 1 Data analysis of the siRNA screen. a Schematic outline of the assay. J774-CD1d cells were transfected with siRNA pools, 36 h later these cells were
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NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06646-8 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:4279 | DOI: 10.1038/s41467-018-06646-8 | www.nature.com/naturecommunications 3
sterols; and Fdz4, a member of frizzled gene family (Fig. 4a). We
analyzed selected genes affecting CD1d presentation for their
inﬂuence on surface expression of MHC antigen-presenting
molecules. Knockdown of several of the selected genes that
reduced CD1d surface expression, such as Pfn3, also caused a
statistically signiﬁcant decrease in surface expression of Kd and
Dd MHC class I molecules (Supplementary Fig. 3A). Similarly,
regarding effects on MHC class II surface expression, only
knockdown of Fut4, Psap, and Pigo caused decreased MHC-II
expression (Supplementary Fig. 3B).
CD1d loads phospholipid antigens in the ER and acquires GSL
antigens predominantly in lysosomes. To determine if complexes
of CD1d with αGalCer were diminished following gene knock-
down, despite equivalent amounts of surface CD1d expression,
we made use of the monoclonal antibody (mAb) L363 that
speciﬁcally detects αGalCer-CD1d complexes29 (Supplementary
Fig. 4). Knockdown of most of the selected 48 genes reduced the
amounts of antigen-CD1d complexes on the cell surface
detectable by ﬂow cytometry (Fig. 4b). The molecules that fall
in this category include several cytoskeletal proteins, proteins
involved in vesicular and cargo trafﬁc in endosomes and
lysosomes, and proteins present in mitochondria or the plasma
membrane. For 10 of the genes, however, the decrease in staining
for αGalCer-CD1d complexes was not statistically signiﬁcant,
perhaps reﬂecting variability in the knockdown and mAb staining
in different experiments. It is also possible that some of these
knockdowns affected the concentration of CD1d into lipid rafts
or nanoclusters on the plasma membrane, which is important for
iNKT cell stimulation30, without diminishing the total lipid
antigen-CD1d detectable with L363 on the cell surface.
CD1d and MHC-II antigen presentation pathways both depend
on antigen loading in acidic late endosomal or lysosomal
compartments, therefore we analyzed the role of the the 48
identiﬁed genes in MHC class II antigen presentation to assess the
extent to which the two pathways overlap. After siRNA-mediated
knockdown, J774-CD1d cells were incubated with ovalbumin
(OVA) and cultured with CD4+ T cells isolated from OVA-
speciﬁc DO11.10 × Rag−/− TCR transgenic mice. Our results
indicate that only some of the gene knockdowns affected MHC
class II antigen presentation to the extent that CD1d antigen
presentation was affected (<30%), and only 9 reached <50% when
compared to the control (Supplementary Fig. 5). Among the genes
most affecting MHC class II presentation by the J774-CD1d cells
were the Rhob, Mbd2, and Tsg101. These three genes have been
shown to affect MHC-II antigen presentation previously31–33.
Therefore, the pathway leading to GSL antigen uptake, processing,
and presentation by CD1d is in part distinct from protein
processing and presentation by MHC class II.
Effects on lipid antigen uptake. To better understand the speciﬁc
role(s) of the molecules identiﬁed in the screen, we analyzed the
effect on antigen localization, by using confocal microscopy to
follow the uptake of Bodipy-labeled αGalCer into lysosomes of
J774-CD1d cells. We analyzed four genes that affected antigen-
CD1d complex formation without decreasing CD1d surface
expression signiﬁcantly (Fig. 5a and Supplementary Fig. 6), some of
which were not known previously to be involved in antigen pre-
sentation. These included the following: (1) Dedicator of cytokinesis
2 (Dock2), a guanine nucleotide exchange factor involved in actin
polymerization that inﬂuences several processes, including phago-
cytosis and antigen uptake by dendritic cells (DC)34. (2)
Synaptosome-associated protein 29 (Snap29), which is part of the
SNARE complexes involved in membrane fusion. It has been
reported to be involved in mast cell phagocytosis35, but has not
been associated with antigen presentation. (3) Tumor susceptibility
gene 101 (Tsg101), which is a component of the endosomal sorting
complexes required for transport I (ESCRT-I) that binds to ubi-
quitinated cargo proteins and is required for their sorting into
multivesicular bodies and exocytosis36. It may be involved in the
trafﬁcking of MHC class I molecules that are ubiquitinated and
degraded following Kaposi sarcoma virus infection37, and also plays
a role in mannose receptor-mediated cross-presentation of antigens
in the class I pathway38. (4) Vacuolar protein sorting-associated
protein homolog 11 (Vps11) a HOPS complex member involved in
endosome-lysosome fusion, which was previously reported to be
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Fig. 2 Decreased lipid antigen presentation after knockdown of identiﬁed genes. J774-CD1d cells were transfected with siRNA pools, 36 h later these cells
were loaded with GalGalCer for 6 h before culture with an iNKT cell hybridoma. Sixteen hours later supernatant was used to perform IL-2 Alpahlisa. Plot of
normalized IL-2 release for selected hits compared to control. An average of three experiments is shown. Boxes represent the interquartile range;
maximum and minimum values are displayed with vertical lines. p-Values are indicated (paired t-test)
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06646-8
4 NATURE COMMUNICATIONS |  (2018) 9:4279 | DOI: 10.1038/s41467-018-06646-8 | www.nature.com/naturecommunications
important for lipid antigen presentation by mouse CD1d25. A sig-
niﬁcant knockdown was observed at the protein level for all the four
genes (Supplementary Fig. 7). In the absence of speciﬁc gene
knockdown, we observed that the maximum accumulation of
labeled antigen in lysosomes was reached at 2 h. Knockdown of
Snap29 or Tsg101 greatly reduced localization of antigen to lyso-
somes, knockdown of Vps11 delayed antigen localization, but
knockdown of Dock2 had no effect (Fig. 5b, c).
Effects on CD1d localization. Because trafﬁcking of CD1d to
lysosomes is important for the acquisition of GSL antigens2,13,27,
we used confocal microscopy to obtain a quantitative analysis of
the localization of CD1d in the J774-CD1d cells at steady state.
We used Rab5 as a marker for early endosomes and Lamp1 for
late endosomes and lysosomes. Knockdown (Supplementary
Fig. 7) of Snap29, Vps11 and Dock2 led to a signiﬁcantly
decreased localization of CD1d into Lamp1+ compartments
(Fig. 6a, c), and for Vps11 and Dock2, there was a signiﬁcant
increase in the accumulation of CD1d in Rab5+ early endosomes
(Figs. 6b and 7). Reduced expression of Tsg101 did not lead to a
highly altered intracellular distribution of CD1d, although the size
and distribution of Lamp1+ compartments appeared different in
some frames, the difference was not signiﬁcant when many cells
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Fig. 3 Network analysis of the identiﬁed genes. Three major networks containing >5 genes were identiﬁed using IPA. Figure represents one out of three
networks that include genes with functions related to cellular assembly and organization, molecular transport, and protein trafﬁcking. See also
Supplementary Fig. 2
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were quantitated (Supplementary Fig. 8). As summarized in
Supplementary Fig. 9, genes that affect the ability of CD1d to
localize in lysosomes, such as Dock2, Snap29, and Vps11, or that
affect the ability of GSL antigens to trafﬁc there, such as Snap29
and Tsg101, impaired the presentation of GalGalCer without
diminishing the surface expression of CD1d.
Abcc1 deﬁciency results in diminished iNKT cell activation.
Although αGalCer is internalized to late endosomes in APC39, and
presentation of αGalCer is enhanced when it is taken up by cells40,
this antigen also can load into CD1d on the cell surface, and unlike
GalGalCer, can be presented by cells expressing a form of CD1d
that cannot localize to endosomes39. Therefore, the genes that affect
the response to GalGalCer more than αGalCer, likely function in
either carbohydrate processing or antigen and/or CD1d trafﬁcking
to lysosomes. The response to GalGalCer compared to the response
to αGalCer of the 48 hits was >1.5-fold higher for 13 of the genes,
and 2-fold greater for 5 including Abcc1, which had the highest
increase (Fig. 8a). In every case, however, the knockdowns also
inhibited the αGalCer response to some extent (Supplementary
Fig. 10). Among these GalGalCer-selective genes were Elmo1, pre-
viously shown to be involved in phagocytosis41, and Psap, impor-
tant for lipid loading of CD1d in lysosomes42–44. Abcc1, which
encodes the multidrug resistance protein 1 (Mrp1), intrigued us
because Mrp1 is a member of the ATP-binding cassette (ABC)
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Fig. 4 Gene knockdown effects on surface CD1d and CD1d-lipid complex formation. a Effect on CD1d surface expression assessed by ﬂow cytometry. The
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family of transporter molecules, which also includes the transporter
associated with antigen processing (TAP), required for peptide
loading and surface expression of MHC class I molecules.
Like the majority of the other hits, knockdown of Abcc1 led to
reduced antigen-lipid complex without changing CD1d surface
expression (Figs. 4 and 8b, c). To validate a role for this protein,
we analyzed peritoneal macrophages from Abcc1−/− mice for
their ability to present lipid antigens to an expanded line of
mouse iNKT cells. We observed peritoneal macrophages were
defective in antigen presentation of αGalCer and GalGalCer
(Fig. 8d). To test antigen presentation function in vivo, we
injected αGalCer and measured interferon gamma (IFNγ) and IL-
4 in the sera by enzyme-linked immunosorbent assay (ELISA).
The response by Abcc1−/− mice was lower compared to the FVB
parental strain (Fig. 8e). Despite this, the percentage of iNKT cells
in thymus and spleen was undiminished in Abcc1−/− mice, and
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the percentage in the liver was decreased only moderately
(Supplementary Fig. 11).
Because antigen-dependent activation of iNKT cells is critical for
protection of mice from S. pneumoniae45,46, we analyzed activation
of iNKT cells after infection and the survival of Abcc1−/−mice. The
method for gating of lung iNKT cells is shown in Supplementary
Fig. 12. Production of IFNγ by TCR-activated iNKT cells was
reported to be protective following S. pneumoniae infection46, and
in Abcc1−/− mice, this response was blunted (Fig. 8f). Furthermore,
Abcc1−/− mice had decreased survival and increased bacteria in
their lungs at day 2 after infection (Fig. 8g). Therefore, in vitro and
in vivo data support the conclusion that lipid antigen presentation
by CD1d is decreased in primary APC from Abcc1−/− mice, and
this likely has an effect on the host protective immune response
early after infection, although effects on cell types other than
iNKT cells were not excluded.
Abcc1 deﬁciency results in altered CD1d distribution. To
identify the mechanism(s) by which Abcc1 acts on lipid antigen
presentation, we analyzed antigen and CD1d trafﬁcking in peri-
toneal macrophages from gene-deﬁcient mice, as described above.
The expression of CD1d on the surface of F4/80+ peritoneal
macrophages from Abcc1−/− mice was not reduced (Supple-
mentary Fig. 13A). When the accumulation of αGalCer-Bodipy in
lysosomes was measured, there was only a moderate decrease,
especially at the 2 h time (Supplementary Fig. 13B). We observed
a much more striking difference in the distribution and
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localization of CD1d. There was a reduction in CD1d co-
localization with Lamp1+ late endosomal compartments (Fig. 9a).
Furthermore, the average size of the Lamp1+ vesicles in macro-
phages from Abcc1−/− mice was decreased (Fig. 9b). These
alterations in late endosomes and lysosomes likely contribute to
the pronounced effect of Abcc1 knockdown on the response to
GalGalCer.
Abcc1 deﬁciency also led to alterations in the plasma membrane
that likely affected lipid antigen presentation. In macrophages from
Abcc1−/− mice, the density of lipid rafts in the membrane was
decreased (Fig. 10a, b). Furthermore, CD1d co-localization with lipid
rafts was diminished, and the size of CD1d clusters on the cell surface
was reduced (Fig. 10a, c). Therefore, altered membrane biosynthesis
in cells from Abcc1−/− mice is likely an underlying cause of changes
in CD1d distribution that led to reduced antigen presentation.
Discussion
As a model system to gain deeper insight into the presentation of
nonpeptide antigens, we analyzed the genetic control of the
presentation of GSL antigens by CD1d to iNKT cells, a T-cell type
that is prominent because of its distinct behavior and inﬂuence on
many types of immune responses47. Few of the selected knock-
downs decreased surface CD1d expression, and instead, the
majority decreased the formation of αGalCer complexes with
CD1d. Long-lived CD1d molecules recycle from the cell surface
through early endosomes, followed by trafﬁc to lysosomes before
return to the cell surface17,48. Uptake of GSL antigens, their trafﬁc
to lysosomes, carbohydrate processing, and loading into CD1d is
also a multifaceted process. Therefore, a decrease in the formation
of GSL-CD1d complexes on the cell surface could be due to
deﬁcit in any one or more of these processes.
Consistent with the requirement for complex intracellular
trafﬁcking events, our results implicated components involved in
various parts of the endosomal and lysosomal systems, including
ESCRT-I, HOPS, and SNARE complexes, and as well as proteins
involved in cytoskeletal rearrangements. Tsg101 is a member of
the ESCRT-I complex that binds to ubiquitinated cargo proteins.
Although human CD1d can be ubiquitinated on a lysine in its
cytoplasmic tail49, mouse CD1d does not have this lysine, and
therefore the action of Tsg101 likely is not directly on the CD1d
protein. Consistent with this, the primary effect of Tsg101 gene
knockdown was impaired localization of GSL antigen to lyso-
somes. Knockdown of HOPS complex member Vps11 caused a
delay in antigen trafﬁc to lysosomes and also reduced CD1d
localization there. Our data are consistent with an earlier report
showing similar effects of knockdown of HOPS complex reg-
ulator Arl8b25. Knockdown of SNARE complex gene Snap29 led
to a pronounced reduction in antigen trafﬁcking to lysosomes and
decreased CD1d in LAMP1+ vesicles. Although ESCRT, HOPS,
and SNARE complex proteins all have been reported to regulate
autophagy50, knockdown of macroautophagy genes, such as Atg7,
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did not have a strong effect on iNKT cell responses, consistent
with a recent report51. A more recent study, however, indicated a
role for Atg5 in inhibiting CD1d antigen presentation52. Similar
to Vps11 and Snap29, Dock2 gene knockdown also reduced CD1d
accumulation in lysosomes. Dock2 affects the actin cytoskeleton,
which recently has been shown to regulate the efﬁciency of
antigen presentation by affecting the size and mobility of CD1d
nanoclusters on the cell surface30. Elmo1, involved in phagocy-
tosis53, interacts constitutively with Dock2 in some cell types54
and also was identiﬁed by the screen.
We found that gene knockdown of several members of the
ABC transporter family had effects on lipid antigen presentation,
although only knockdown of the Abcc1 gene, which encodes
Mrp1, met our criteria for deeper investigation. We conﬁrmed the
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role of Mrp1 in CD1d antigen presentation in vitro and in vivo,
which correlated with reduced iNKT cell activation and increased
susceptibility of Abcc1-deﬁcient mice to S. pneumoniae. In con-
trast to our study, a previous publication reported that Mrp1-
deﬁcient mice were protected against S. pneumonia55. This dif-
ference might be attributed to the different serotypes of S.
pneumonia used, as some strains might be less dependent on
iNKT cells for protection. Furthermore, there were differences in
the dose and route of infection, retropharyngeal in our experi-
ments as opposed to intranasal. A study on Mycobacterium
tuberculosis agreed with the outcome of our work in showing that
Mrp1-deﬁcient mice were more susceptible to infection by
inhalation, although the role of iNKT cells to susceptibility was
not examined56. Also, differences in the background of the mice
used must be considered, as the study by Schulz et al. used (129/
Ola)/FVB (50%/50%) mice, whereas the mice that we used and in
Verbon et al. were pure FVB background. We recently reported
that another ABC family transporter, Abca7, also regulated the
number of lipid rafts and the co-localization of CD1d in lipid
rafts57. Unlike Mrp1, however, there was reduced CD1d surface
expression in double-positive thymocytes in Abca7−/− mice,
providing a connection to the decreased positive selection of
Fig. 8 Role of Abcc1 in lipid antigen presentation. a After knockdown, J774-CD1d were treated with either αGalCer or GalGalCer and cultured with an iNKT
cell hybridoma before measuring IL-2. Figure represents the fold change in IL-2 secretion comparing the normalized response to αGalCer with GalGalCer.
Genes that showed >1.5-fold more IL-2 in case of αGalCer are plotted. Figure represents the average of two experiments. b Comparative plots of surface
CD1d expression, CD1d-lipid complex formation, and IL-2 release after knockdown of Abcc1 in J774-CD1d cells. Figure represents the average of three
experiments. c Figure represents the decrease in surface CD1d-lipid complex expression by J774-CD1d cells after knocking down Abcc1 after loading with
GalGalCer. d Peritoneal macrophages were isolated from wild-type (WT) and Abcc1−/− mice, loaded with αGalCer and GalGalCer at the indicated
concentrations and incubated with a mouse iNKT cell line before IFNγmeasurement. Figure shows the representative plots from one of two experiments. e
WT and Abcc1−/− mice were injected i.v. with αGalCer and IFNγ and IL-4 was measured after 2 h of injection. Figure shows the representative plots from
one of two experiments. f WT and Abcc1−/− mice were infected with 2.5 × 106 S. pneumonia for 14 h followed by intracellular cytokine staining of gated,
lung iNKT cells (See Supplementary Fig. 12). Figure represents the percent IFNγ positive cells in uninfected, and infected WT and Abcc1−/− mice. Figure
shows the representative plots from one of two experiments in which pooled cells from two mice for FVB and three mice for Abcc1−/− mice were analyzed.
g WT and Abcc1−/− mice were infected with 0.5 × 105 S. pneumonia and after 2 days lung CFU were measured. Data are representative from one of the
three experiments. Graphs represent mean ± SD. *p < 0.05; **p < 0.01 (one-way ANOVA). See also Supplementary Fig. 10 and 11
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iNKT cells. Although Abca7 deﬁciency did not greatly reduce the
immune response using iNKT hybridoma cells, our earlier work
showed that Abca7−/− mice had a decreased lipid antigen
response in vivo and macrophages from these mice had a reduced
ability to present antigen to expanded lines of primary
iNKT cells57. Therefore, the hybridoma cells may have provided a
less sensitive readout than primary iNKT cells.
While Mrp1 had been reported to be a plasma membrane
transporter mediating the efﬂux of anticancer drugs58,59, because
of its selective effect on GalGalCer responses, Abcc1 gene
knockdown also may have inﬂuenced aspects of the antigen
presentation process occurring deep in the endolysosomal system.
Using inhibitor compounds, Mrp1 previously had been reported
to be involved in the transport of sulfatide, a GSL, across the
membrane of human DC60, suggesting Mrp1, perhaps with other
ABC transporters, could be a TAP-equivalent for transport of
lipid antigens. The most profound alteration due to the absence of
Mrp1, however, was in the trafﬁcking of CD1d, not in antigen
localization. There was reduced CD1d co-localization in both late
endosomes and in lipid rafts, and it has been shown that dis-
ruption of these structures led to diminished iNKT cell stimula-
tion61–63. Interestingly, loading of lipid antigens into CD1d in low
8
15 25
Colocalization
signal and HoechstCholera toxinCD1d
20
15
10
5
0
15
10
5
0
10
5
0
ns
ns
WT
Ab
cc1
–
/–
WT
Ab
cc1
–
/–
WT
Ab
cc1
–
/–
WT
W
T
Ab
cc1
–
/–
Ab
cc
1–
/–
WT
Ab
cc1
–
/–
WT
Ab
cc1
–
/–
***
**
***
**
6
Av
e
ra
ge
 n
u
m
be
r o
f
CT
X+
 lip
id
 ra
fts
 p
er
 c
el
l
Av
e
ra
ge
 a
re
a 
of
CD
1d
+
 v
e
si
cl
es
 p
er
 c
el
l (μ
m
2 )
Av
e
ra
ge
 n
u
m
be
r o
f
CD
1d
+
 v
e
si
cl
es
 p
er
 c
el
l
In
te
gr
a
te
d 
de
ns
ity
 o
f
CT
X+
 
lip
id
 ra
fts
In
te
gr
a
te
d 
de
ns
ity
 o
f
CD
1d
Av
e
ra
ge
 a
re
a 
of
CT
X 
lip
id
 ra
fts
 p
er
 c
el
l (μ
m
2 )
4
2
0
8
6
4
2
0
8
c
b
a
6
4
2
0
Fig. 10 Alterations in CD1d and lipid rafts in Abcc1−/− mice. a Peritoneal macrophages from wild-type (WT) and Abcc1−/− mice were stained with anti-
CD1d, Cholera toxin B (CTX) along with Hoechst for staining nucleus. Images were acquired using confocal microscopy. Figure shows representative
images for the localization of CD1d in CTX+ compartment in peritoneal macrophages at steady state. b Figure represents the number of Cholera toxin
(CTX+) vesicles, average area of CTX+ vesicles, and integrated density of CTX expression. c A compilation of the number of CD1d vesicles, average area of
CD1d vesicles, and integrated density of CD1d expression on the cell surface. Representative images from one of two experiments with at least 100 cells
per condition. Scale bar 10 μm. Graphs represent mean ± SEM. **p < 0.01; ***p < 0.001 (one-way ANOVA). See also Supplementary Fig. 13
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06646-8
12 NATURE COMMUNICATIONS |  (2018) 9:4279 | DOI: 10.1038/s41467-018-06646-8 | www.nature.com/naturecommunications
pH endosomal compartments is correlated with the appearance of
these lipid antigen-CD1d complexes on the cell surface in lipid
rafts64,65, suggesting a connection between the lysosomal site of
antigen loading and appearance of the antigen on the cell
membrane in complex with CD1d in detergent resistant micro-
domains. The effects of Mrp1 deﬁciency were not selective for
CD1d, however, as we detected decreases in the number and size
of membrane lipid rafts and Lamp1+ vesicles. Overall, these
ﬁndings indicate a larger role for Mrp1 in several aspects of
lysosomal membrane biogenesis, consistent with its increased
inﬂuence on GalGalCer responses.
Comparing our results to those from a genome-wide screen for
elements affecting MHC class II presentation of peptides by
human cells did not reveal any genes in common with the CD1d-
mediated presentation pathway66. Neither screen was compre-
hensive, perhaps because as noted, the knockdowns were not
complete, and also, a small number of residual antigen-antigen-
presenting molecule complexes may be sufﬁcient to activate
T cells in some contexts. Nevertheless, the lack of overlap between
the CD1d and MHC class II pathway is surprising. iNKT cells
apparently do not use a TCR co-receptor, and therefore we
speculate that iNKT cell activation may require increased clus-
tering of CD1d in membrane microdomains or lipid rafts. While
MHC class II presentation also has been shown to require lipid
rafts, this was observed only at low antigen concentrations67–69.
In summary, a genome-wide screen has identiﬁed a set of genes
that positively regulate CD1d presentation of lipid antigens,
including ABC family transporters and others involved in the
endolysosomal network, including genes that had not been
associated previously with antigen presentation in any system.
Considering the conservation between mice and humans for
CD1d antigen presentation6, the selected genes from this screen
may be applicable to efforts to modulate the activity of human
iNKT cells. Furthermore, they may be implicated in presentation
to other T lymphocytes reactive with lipid antigens presented by
group I CD1 molecules.
Methods
Cell culture and reagents. J774-CD1d, a mouse Cd1d1.1 transfectant of the
J774A.1 (American Type Culture Collection) macrophage cell line70 and iNKT cell
hybridoma DN3A4-1.271,72 were cultured at 37 °C under 5% CO2 in Dulbecco’s
modiﬁed Eagle’s medium containing 10% heat-inactivated fetal bovine serum
(FBS), 100 U/ml penicillin, 100 U/ml streptomycin, 2 mM L-glutamine, 1 mM
sodium pyruvate, and 10 mM HEPES. Antibodies used against various proteins
along with their dilutions and catalog number are as follows: PE Rat Anti-Mouse
CD1d (1:100, 553846); Mouse Anti-Mouse H-2K[d] (1:200, 553566); Puriﬁed Rat
Anti-Mouse IL-2 (1:250, 554424); Biotin Rat Anti-Mouse IL-2 (1:1000, 554426);
Biotin Rat Anti-Mouse CD8a (1:250, 553029); Biotin Rat Anti-Mouse CD19 (1:250,
553784); FITC Rat Anti-Mouse CD107a (LAMP1) (1:100, 553793); BV786 Rat
Anti-Mouse CD45 (1:200, 564225); Brilliant Violet 605™; BV605 Rat Anti-Mouse
CD19 (1:200, 563148); BV711 Hamster Anti-Rat/Mouse CD49a (1:200, 564863);
and PE Rat Anti-Mouse IL-17A (1:200, 559502) from BD Biosciences. Anti-mouse
CD8α Antibody (1:200, 100743); IFNγ Monoclonal Antibody PerCP-Cy5.5 (1:200,
45-7311-82); αGalCer:CD1d Complex Monoclonal Antibody (L363) (1:150, 12-
2019-82); TER-119 Monoclonal Antibody, Biotin (1:250, 13-5921-85); TCR β
Monoclonal Antibody, APC-eFluor 780 (1:200, 47-5961-82); Biotin CD24 Mono-
clonal Antibody (1:250, 13-0247-82); and CD103 (Integrin alpha E) Monoclonal
Antibody (2E7), FITC (1:200, 11-1031-85) from ebioscience. Rat anti-mouse I-A/I-
E Antibody (1: 200, 107622); Alexa Fluor® 700 anti-mouse CD4 Antibody (1:200,
100430); PE/Cy7 anti-human/mouse/rat CD278 (ICOS) Antibody (1:200, 313520);
and APC anti-mouse CD183 (CXCR3) Antibody (1:200, 126512) from Biolegend.
Rabbit Anti-Mouse Rab5 antibody (1:200, ab18211); Rabbit monoclonal to Tsg101
(1: 1000, ab125011); Rabbit polyclonal to Dock2 (1:1000, ab74659); Rabbit
monoclonal to Vps11 (1:1000, ab170869); and Rabbit monoclonal to Snap29
(1:1000, ab138500) from Abcam. Goat anti-Rabbit AF488 secondary antibody
(1:1000, A-11034) and Goat anti-Rat AF555 secondary antibody (1:1000, A-21434)
from Invitrogen. Anti-rabbit IgG horseradish peroxidase (HRP)-linked (1:2500,
7074) and Anti-mouse IgG HRP-linked (1:2500, 7076) from Cell Signaling Tech-
nology. CD1d tetramer was prepared in-house. αGalCer was obtained from Kyowa
Hakko Kirin Co. and GalGalCer was obtained from the Besra Lab, University of
Birmingham. αGalCer-Bodipy was obtained from Besra Lab, University of Bir-
mingham and from the Howell lab, University of Connecticut. For antigen
presentation and antigen uptake assays, αGalCer, GalGalCer, and αGalCer-Bodipy
are used at 500 ng/ml concentration unless indicated. LIVE/DEAD™ Fixable Yellow
Dead Cell Stain Kit (Thermo Fisher) was used to exclude dead cells during cell
acquisition.
Animals. Mice were bred and housed under speciﬁc pathogen-free conditions in
the vivarium of the La Jolla Institute for Allergy and Immunology (La Jolla, CA).
Wild-type (WT; FVB) parental strain and Abcc1−/− mice were purchased from
Taconic. All procedures were approved by the La Jolla Institute for Allergy and
Immunology Animal Care and Use Committee. Mice of both genders were used
and they were 8–12 weeks old.
siRNA optimization. We performed siRNA titrations against different target genes
in J774-CD1d cells transfected with siGENOME SMARTpool (GE Dharmacon)
siRNA using Interferin-HTS (Polypus) transfection reagent. Total RNA was
extracted using the RNeasy Mini kit (Qiagen) according to the manufacturer’s
instructions. cDNA was synthesized using iScript (Bio-Rad) and real-time PCR was
performed using SYBRgreen (Roche) on a LightCycler instrument (Roche). The
ﬁrst set of experiments, using a range of Cd1d siRNA concentrations from 1 to 100
nM, identiﬁed a 25 nM concentration as optimal, yielding a reduction of
approximately 80% in Cd1d mRNA (Supplementary Fig. 1A). At this concentration
of siRNA, there was approximately a 70–80% decrease in CD1d surface protein
expression (Supplementary Fig. 1B). A kinetic analysis showed knockdown was
maximal at 36–48 h (data not shown). We also tested knockdown of several kinase
genes (Camk2a, Mapk1, Prkcd,Mapk14, and Ptk2b) at 25 and 50 nM concentration
of siRNA. We observed decreases of 60–80% in mRNA levels (Supplementary
Fig. 1C) using 25 nM siRNA, assessed using real-time PCR. Although a greater
knockdown could be achieved at 50 nM, there also was increased cell death;
therefore we selected 25 nM. Following primers are used for real-time PCR-
Cd1d1—F-CTGTCTGCGGGCTGTGAAAT, R-TCCCCAGAATCTCACGA
CATATT
Camk2a—F-CCCTGGAATGACAGCCTTTGA, R-CCGGGACCACAGGTT
TTCA
Mapk1—F-ACCAACCTCTCGTACATCGGA, R-AGCAAACCATGCCGTA
GGC
Prkcd—F-AACCGTCGTGGAGCCATTAAA, R-GGCGATAAACTCGTGGT
TCTTG
Mapk14—F-ACCTAGCTGTGAACGAAGACT, R-GTAGCCACGTAGCCTG
TCATC
Ptk2b—F-AGGTATGACCTTCAAATCCGCT, R-CCGGAGCTGTTGATAAA
AGTACA
Western blot. J774-CD1d cells were transfected with 25 nM siGENOME
SMARTpool (GE Dharmacon) siRNA using Interferin-HTS (Polypus) transfection
reagent. Thirty-six hours post transfection, cells were directly lysed in RIPA buffer
supplemented with a protease and phosphatase inhibitor cocktail (Thermo Fisher)
on ice for 30 min. Protein concentrations were measured using BCA assay kit
(Thermo Fisher). Protein lysates were analyzed by SDS–polyacrylamide gel elec-
trophoresis (Bio-Rad) and membranes were blotted with primary antibodies
(Abcam), followed by secondary antibody (Cell signaling). Blots were developed
using luminol reagent (Santa Cruz). Blots were stripped using stripping buffer (Cell
signaling) and reprobed for loading control (β-actin—Cell Signaling). Quantitation
on bands was performed using Quantity One software.
Workﬂow of screen. We used the mouse siGENOME siRNA Library SMARTpool
(GE Dharmacon). J774-CD1d cells (3.5 × 103 cells/well) were ﬁrst transfected with
individual target-speciﬁc siRNA pools using reverse transfection in 384-well plates.
A transfection mixture consisting of siRNA, Optimem (Gibco) and Interferin-HTS
was prepared using a liquid handler Hamilton STAR and cells were plated using
Wellmate (Thermo Fisher). Approximately 40 h post transfection, cells were loaded
with GalGalCer at a concentration of 500 ng/ml for 6 h, and later antigen was
removed and DN3A4-1.2 iNKT cell hybridoma cells (3.5 × 103/well) were added.
These cells express a TCR encoded by Vβ8.2 (Trbv13-2) paired with the invariant
Vα14 (Trav11-Traj18) α chain. After 15 h, 5 μl supernatant was used for an
AlphaLISA-based IL-2 measurement (Perkin Elmer) using Beckman Coulter Bio-
mek FXP liquid handler, and CellTitre blue (Promega) was added to the remaining
cells to determine cell viability for 2 h. IL-2 release is a surrogate marker for TCR
engagement. Each 384-well plate consisted of 2 wells each of the siGLO control,
which is used for assessing siRNA uptake, a Tox siRNA control, which causes cell
death and can be used to assess transfection efﬁciency, and negative controls, which
contain two non-targeting siRNA pools. As a positive control for knockdown, we
used Cd1d and B2m siRNAs. Every plate also had wells containing hybridoma cells
and J774-CD1d cells either only with transfection reagent (cells only) or a trans-
fection reagent along with antigen but containing no siRNA (cells+GalGalCer),
and background-only wells containing just media (no cells) (Supplementary
Fig. 1D). The primary screen was performed in duplicate. Alphalisa (Perkin Elmer)
was performed using the collected supernatant according to the manufacturer’s
instructions. Brieﬂy, anti-mouse IL-2 acceptor beads and biotinylated anti-IL-2
antibody were incubated with supernatant for 60 min. Streptavidin donor beads
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were added for 30 min in the dark before reading the plate using EnVision plate
reader (Perkin Elmer). CellTitre blue assay was performed for testing viability using
EnVision plate reader (Perkin Elmer).
Data analysis. Analysis of every plate was performed with help from the bioin-
formatics core at the La Jolla Institute for Allergy and Immunology. First, a quality
metrics was calculated based on positive and negative controls in each plate.
Positive controls include Cd1d and B2m and a negative control was mock trans-
fection followed by GalGalCer antigen (cells+GalGalCer). Plates were considered
to have been assayed successfully if they showed a 70% decrease in the response to
antigen when Cd1d and B2m expression were knocked down compared to controls.
To exclude knockdowns that were generally toxic to the cells, knockdowns that
showed cell viability below 50% of the control were excluded. We chose a mini-
mum viability threshold of 50% based on this value being exceeded by 98% of all
B2m and Cd1d knockdowns in different plates. We considered 30% or less pro-
duction of IL-2 a signiﬁcant knockdown based on 85% of the B2m and 73% of the
Cd1d knockdowns achieving that threshold (Supplementary Fig. 1E), while none of
the 201 wells with non-targeting siRNAs or cells with only transfection reagent in
the entire screen achieved such a reduction.
RNA isolation and microarray. A microarray analysis was performed for the
expression of genes in J774-CD1d cells and sorted peritoneal macrophages (F4/80
+) obtained directly from BALB/c mice. RNA was isolated using RNeasy mini kit
(Qiagen) according to the manufacturer’s instructions. Microarray was performed
at UC San Diego Microarray Core facility using Affymetrix Mouse Gene 1.0 ST
Array that interrogates 28,853 well-annotated genes with 770,317 distinct probes.
All microarray data sets were processed in R, using customized scripts and Bio-
conductor modules. Raw intensity data were normalized with the “rma” function,
with default parameters. A cutoff of 40, a measure of signal strength, was used to
exclude genes expressed at a very low level. Microarray data were deposited in the
Gene Expression Omnibus database. The assigned accession
number is GSE109717.
GO analysis. We have employed the Bingo 2.44 plug-in into Cytoscape 2.8.3 to
classify genes into different GO classes. In Bingo 2.44 we have used GO Slim
generic for the clustering of genes, as determined by hypergeometric statistical test
employing the Benjamini and Hochberg false discovery rate correction21. GO Slims
are cut-down versions of the GO containing a subset of the terms in the whole GO.
Ingenuity Pathway Analysis. A core analysis was performed on identiﬁed genes
using IPA Ingenuity Knowledge Base (Genes only, Version 01-13) reference set and
all default settings. Networks of these genes were algorithmically generated based
on their interrelationships. Experimentally observed direct relationships were used
to generate these networks.
Confocal microscopy and image processing. Resident mouse peritoneal mac-
rophages from WT FVB strain or Abcc1−/− mice were obtained by lavage of
peritoneum with phosphate-buffered saline (PBS). After washing with PBS, cells
were seeded on to a tissue culture plate in RPMI+ 20% FBS for 2 h at 37 °C,
supernatant was removed and adherent cells were seeded onto glass coverslips pre-
coated with ﬁbronectin (neuVitro) in 12-well tissue culture plates. Cells were ﬁxed
in 4% paraformaldehyde (Sigma) in PBS for 15 min at room temperature. Fixed
cells were permeabilized using 0.2% Triton X-100 in PBS for 15 min, cells were
then incubated in blocking buffer (10% FBS in PBS) for 1 h prior to a 45 min to 1 h
incubation with respective primary antibodies (diluted using blocking buffer) fol-
lowed by three washes with PBS/T (0.5%Tween 20 in PBS) and a single wash with
PBS. Cells were further incubated with secondary antibody for 45 min, washed with
PBS/T, and incubated with NucBlue® (Hoechst) Fixed Cell Reagent (Thermo
Fisher) in PBS for 5 min for nuclear staining followed by three washes with PBS.
For lipid raft staining we used Cholera Toxin Subunit B AF488 (Invitrogen) at a
dilution of 1:1000 in PBS for 45 min before staining with Hoechst. All coverslips
were mounted on slides with antifade (Thermo Fisher). A similar procedure was
also performed for staining J774-CD1d cells after siRNA transfection. For lysosome
staining, LysoTracker Red DND-99 (Thermo Fisher) was added at a dilution of
1:10 000 in cell culture media for the last 2 h of chase.
Multi-labeled slides of samples were imaged with an Olympus FV10i Laser
Scanning Confocal microscope (Olympus, Center Valley, PA) or a Zeiss LSM 780
Laser Scanning Confocal Microscope (Zeiss, Thornwood, NY). Using either the
FV10i or Zeiss Zen acquisition software, each circular coverslip containing cells
was separated into three or four ﬁelds of view, which were acquired and a multi-
tiled large image comprised of 3 × 3 or 4 × 4 panels were acquired per ﬁeld. Each z
series panel (1024 × 1024) was serially acquired with a ×60 or ×63 objective using a
mechanical step size of 0.3 mm between sections and then stitched together
through a 10% overlap with the Olympus FluoView 1000 (Olympus) or Zeiss Zen
imaging software. Multi-labeled images were maximum projected and imported
into Image Pro Premier (IPP) (Media Cybernetics, Inc MD) for further quantitative
analysis, including co-localization assessment. For comparison, images were also
imported into the Zeiss Zen software and analyzed using the Zen co-localization
module. Quantitative analysis of staining intensity/dynamic range was obtained
after thresholding whereby we deﬁned true signals based on control samples. These
thresholds of dynamic range were used to obtain Manders correlation coefﬁcients
of the various paired stainings using the IPP and ZEN co-localization modules.
Thresholds above background were also used in IPP to outline all cells (based on
nuclear signal), which was dilated within the software to outline the entire cell.
These whole cell outlines were deﬁned as regions of interest from which all
intracellular quantitative measurements of CD1d, Lamp1, and Rab5 signal were
extracted, including average area, intensity, and integrated density. The parent-
child module in IPP was used to deﬁne the cell outline as the parent and the
children being the various intracellular markers of the trafﬁcking pathway. Each of
these ﬂuorescently labeled organelles per cell were automatically outlined by the
software and measurements extracted were imported into excel for further
processing. An average of two or three experiments and 100–200 cells/condition
are represented in ﬁgures.
Mouse cell preparation. Splenocytes and thymocytes were harvested by
mechanical disruption on 70 µm nylon mesh followed by red blood cell (RBC) lysis
and washing with RPMI supplemented with 10% FBS. For lung, tissue was digested
with Stemcell spleen dissociation medium, and mechanically dissociated using
GentleMacs Dissociator (Miltenyi). Tissues were strained though a 70 µm ﬁlter and
washed with RPMI supplemented with 10% FBS followed by RBC lysis. For liver
preparation, cells were harvested by mechanical disruption on 70 µm nylon mesh
followed by 34% percoll gradient before RBC lysis and washing.
Flow cytometry. For staining of cell surface molecules, cells were suspended in
staining buffer (PBS, 1% bovine serum albumin (BSA), and 0.01% NaN3) and
stained with ﬂuorochrome-conjugated antibody at 0.1–1 μg/107 cells for 15 min in
a total volume of 50 μl. FcγR-blocking Ab anti-CD16/32 (2.4G2, prepared in-
house) was added to prevent nonspeciﬁc binding. Cells were analyzed with LSR II
(BD Biosciences), and data were processed with DIVA (BD Bioscience) or Flow Jo
(Tree Star, Ashland, OR) software.
Mouse Vα14i NKT cell line. Thymocytes from WT mice were enriched for Vα14i
NKT cells by magnetic depletion using biotinylated antibodies against CD8α,
CD19, CD24, and TER-119 (BD Biosciences and eBioscience) together with
EasySep magnets and protocols and reagents from StemCell Technologies. Cells
were then stained with αGalCer-loaded CD1d tetramers, together with anti-TCRβ
antibodies, in staining buffer containing 1 μg/ml streptavidin. Tetramer-positive,
TCRβ+ cells were isolated using a FACSAria cell sorter (BD Biosciences). Sorted
Vα14i NKT thymocytes were then cultured for 48 h at 106/ml in complete RPMI
media on a plate coated with anti-TCRβ antibody together with soluble anti-CD28.
Cells were then maintained by culture in complete RPMI media with 10 ng/ml
mouse IL-15/IL15Ra (eBioscience) for 5 days before being used in experiments.
Antigen presentation assay using Vα14i NKT cells. Resident peritoneal mac-
rophages were isolated from WT and Abcc1−/−mice. Cells were washed and plated
onto a 96-well plate. Macrophages were then incubated with αGalCer and Gal-
GalCer at concentrations indicated for 6 h. Antigen was washed away, and mac-
rophages were incubated with the mouse Vα14i NKT cell line overnight. After 16 h,
cell supernatants were collected and IFNγ was measured by ELISA (eBioscience)
according to the manufacturer’s protocol.
Lipid injection in mice. Mice were injected with 1 µg of αGalCer intravenously,
and the sera of immunized mice were subjected to sandwich ELISAs to measure
mouse IFNγ and IL-4 levels.
S. pneumoniae infection. S. pneumoniae URF918 were cultured in Todd-Hewitt
broth (BD) at 37 °C in an incubator at 5% CO2, collected at a mid-log phase and
washed twice in PBS. For induction of pulmonary infection, mice were anesthetized
with isoﬂurane and restrained on a small board. Mice were inoculated with S.
pneumoniae (3 × 106 to 1 × 107 colony-forming units in a volume of 50 μl/mouse)
by insertion of a 24-gauge catheter into the trachea. For calculating the lung
bacterial burden, tissues were collected at day 2 after infection and were homo-
genized in PBS. Homogenates were inoculated at different dilutions in a volume of
100 μl on 5% (vol/vol) sheep blood Mueller-Hinton agar plates and cultured for 18
h, followed by colony counting. For IFNγ staining after infection, lung cell sus-
pensions were incubated for two hours at 37 °C in RPMI supplemented with 10%
FBS and BD GolgiPlug (1:1000 dilution). Cells were washed and ﬁltered again with
RPMI+ 10% FBS. Cells were resuspended in PBS supplemented with 2% BSA and
stained for surface antibodies for 20 min on ice. Cells were permeabilized with
ebioscience 10× perm buffer, diluted to 1× in dH2O, for 5 min. Cells were stained
with intracellular antibodies overnight at 4 °C. Cells were washed and immediately
run on ﬂow cytometer.
CD4+ T-cell culture from DO11.10 TCR transgenic Rag−/− mice. CD4+ cells
were negatively selected using a combination of six biotinylated mAbs (anti-CD8α,
CD11b, CD11c, NK1.1, B220, and TER-119) and anti-biotin microbeads (Miltenyi
Biotec). Before the culture, 96-well plates were coated with 1.0 μg/ml anti-CD3
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mAb diluted in PBS for 3–4 h at 37 °C. Puriﬁed cells were plated along with 1.0 μg/
ml anti-CD28. After 3 days culture cells were re-stimulated with CD3 and IL-2 was
added (20 ng/ml). Cells were IL-2-starved overnight before incubation with J774-
CD1d cells.
MHC-II antigen presentation assay. J774-CD1d (10 000 cells/well) were trans-
fected with various siRNAs in a U-bottom 96-well plate. Twenty-four hours later,
cells were incubated with chicken OVA (Sigma) at a concentration of 1 mg/ml and
expanded CD4+ T cells from DO11.10 TCR transgenic × Rag−/− mouse (20 000
cells/well). Forty-eight hours later IL-2 was measured in the supernatant by ELISA
(BD Pharmingen).
Data availability
Microarray data are deposited in Gene Expression Omnibus and the accession
number is GSE109717. The authors declare that the main data supporting the
ﬁndings of this study are within the article and its Supplementary Information ﬁles.
Extra data are obtained from the corresponding authors upon request.
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